SCHEMBL7092149

SCHEMBL7092149

CN(C)C(=O)c1ccc2c(c1)CCOC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDK2 Q15119 5/20 0.38
PDK1 Q15118 4/20 0.38
PDK3 Q15120 4/20 0.38
PDK4 Q16654 4/20 0.38
PIR O00625 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPK14 Q16539 1/20 0.35
AKR1C3 P42330 1/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549581 0.83 PDK2 (0.43) ALDH1A1HPGDPDK2PDK1PDK3
SCHEMBL8554148 0.82 EGFR (0.36) ALDH1A1HPGDSMN1; SMN2PDK2PDK1
SCHEMBL30041840 0.80 TSHR (0.47) DRD2ALDH1A1SMN1; SMN2PIRMEN1
SCHEMBL21818960 0.80 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ATSHRMAPK1
SCHEMBL7867810 0.80 TSHR (0.47) DRD2ALDH1A1SMN1; SMN2PIRMEN1
SCHEMBL8551575 0.78 DRD4 (0.48) DRD2ALDH1A1CYP3A4HSD17B10CLK4
SCHEMBL8256846 0.78 ALDH1A1 (0.61) ALDH1A1HPGDSMN1; SMN2PDK2PDK1
SCHEMBL28737571 0.78 ALDH1A1 (0.56) ALDH1A1HPGDSMN1; SMN2PDK2PDK1
SCHEMBL22980539 0.78 CA12 (0.45) ALDH1A1HPGDSMN1; SMN2MEN1KMT2A
SCHEMBL8549874 0.78 MEN1 (0.44) DRD2ALDH1A1HPGDSMN1; SMN2PIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345930-A2 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2002050067-A2 PHARMACEUTICAL HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed